CVS Health Co. (NYSE:CVS) Shares Sold by Citizens & Northern Corp

Citizens & Northern Corp trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 5.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,092 shares of the pharmacy operator’s stock after selling 1,573 shares during the quarter. Citizens & Northern Corp’s holdings in CVS Health were worth $1,541,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. USA Financial Formulas raised its stake in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in CVS Health during the fourth quarter worth $32,000. Creekmur Asset Management LLC acquired a new stake in CVS Health in the fourth quarter valued at $34,000. Steph & Co. boosted its position in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CVS Health during the 4th quarter worth $36,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Wells Fargo & Company raised their price objective on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Evercore ISI reduced their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Baird R W upgraded CVS Health to a “hold” rating in a report on Thursday, May 30th. Barclays reduced their price objective on CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Eleven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $73.24.

CVS Health Stock Performance

NYSE:CVS opened at $57.24 on Friday. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The firm has a 50 day simple moving average of $58.50 and a 200-day simple moving average of $64.43. The firm has a market cap of $72.01 billion, a PE ratio of 10.06, a P/E/G ratio of 0.80 and a beta of 0.52. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.21 EPS. On average, equities analysts expect that CVS Health Co. will post 6.52 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.65%. CVS Health’s payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.